Smallpox vaccine

Details Smallpox vaccine Smallpox vaccine

2006-10-03

2006-10-03

Mosher, Mary E. (Department: 1648)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Virus or component thereof

C435S235100, C435S239000, C435S320100, C424S199100

Reexamination Certificate

active

07115270

ABSTRACT:
The invention provides attenuated vaccinia virus vaccines that can be used in methods to prevent or treat small pox in patients, as well as methods of obtaining such vaccines.

REFERENCES:
patent: 4315914 (1982-02-01), Arakawa et al.
patent: 4567147 (1986-01-01), Ooi et al.
patent: 5614193 (1997-03-01), Schmaljohn et al.
patent: 5656465 (1997-08-01), Panicali et al.
patent: 6723325 (2004-04-01), Weltzin et al.
patent: 2 145 477 (1973-03-01), None
patent: 0 157 528 (1985-10-01), None
McClain et al (Journal of Infectious Diseases 175:756-63, 1997).
Jahrling et al (Emerging Infections 4, ed. Scheld et al, ASM Press, Washington DC, 2000,p. 187-199).
Greenberg et al (Lancet 365:398-409, 2005).
Antiviral Agents Bulletin (Oct. 2000, p. 289).
Henderson et al., “Consensus Statement: Smallpox as a Biological Weapon. Medical and Public Health Management,” JAMA 281:2127-2137, 1999.
Jennings et al., “Virus Vaccines,” In: Virus Culture, a Practical Approach, ed. A.J. Cann, Oxford University Press, New York 149-182, 1999.
Kutinova et al., “Search for Optimal Parent for Recombinant Vaccinia Virus Vaccines. Study of Three Vaccinia Virus Vaccinal Strains and Several Virus lines Derived from them,” Vaccine 13:487-493, 1995.
Halstead et al., “Selection of Attenuated Dengue 4 Viruses by Serial Passage in Primary Kidney Cells,” Am. J. Trop. Med. Hyg. 33(4):666-671, 1984.
Kutinová et al., “Influence of the Parental Virus Strain on the Virulence and Immunogenicity of Recombinant Vaccinia Viruses Expressing HBV preS2-S Protein or VZV Glycoprotein I, ” Vaccine 14:1045-1052, 1996.
Lee et al., “Molecular Attention of Vaccinia Virus: Mutant Generation and Animal Characterization,” Journal of Virology 66:2617-2630, 1992.
LeDuc et al., “Current Status of Smallpox Vaccine,” Emerging Infectious Diseases 5:593, 1999.
Liprandi, “Isolation of Plaque Variants Differing in Virulence from the 17D Strain of Yellow Fever Virus,” J. gen. Virol 56:363-370, 1981.
Weltzin et al., “Clonal Vaccinia Virus Grown in Cell Culture as a New Smallpox Vaccine,” Nature Medicine 9:1125-1130, 2003.
Marchevsky et al., “Phenotypic Analysis of Yellow Fever Virus Derived from Complementary DNA,” The American Society of Viral Medicine and Hygiene 5200:75-80, 1995.

Affiliated with

Also associated with

Rating

Smallpox vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Smallpox vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Smallpox vaccine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3713085